Clinical trial update: National Cancer Institute of Canada.
The Breast Cancer Site Group (BCSG) of the National Cancer Institute of Canada (NCIC) Clinical Trials Group (CTG) has conducted a wide variety of clinical trials focussing on large phase III trials of adjuvant chemotherapy, adjuvant hormonal therapy, and optimal delivery of adjuvant radiation therapy. The Group has also fostered, together with the NCIC CTG Investigational New Drug (IND) Program, a series of phase II and phase I/II studies which will be carried through if possible, into the phase III setting.
Pritchard
Kathy
K
Toronto Sunnybrook Regional Cancer Centre. kathy.pritchard@sw.ca
Whelan
Tim
T
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D035843:Biomedical Research / Q000639:trends; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy* / Q000601:surgery; D002170:Canada; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D015337:Multicenter Studies as Topic; D018714:Radiotherapy, Adjuvant
Lancet. 2002 Jun 22;359(9324):2131-9
12090977
Cancer. 2003 Nov 1;98(9):1802-10
14584060
N Engl J Med. 2003 Nov 6;349(19):1793-802
14551341
Int J Cancer. 1999 Sep 9;82(6):893-900
10446459
J Clin Oncol. 1996 Feb;14(2):422-8
8636752
N Engl J Med. 1997 Oct 2;337(14):949-55
9395428
N Engl J Med. 1997 Oct 2;337(14):956-62
9309100
N Engl J Med. 2004 Mar 11;350(11):1081-92
15014181